Search

Your search keyword '"Sampson, John H"' showing total 102 results
Start Over Author "Sampson, John H" Publication Year Range Last 3 years
102 results on '"Sampson, John H"'

1. CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis

Author

Lerner, Emily C., Woroniecka, Karolina I., D’Anniballe, Vincent M., Wilkinson, Daniel S., Mohan, Aditya A., Lorrey, Selena J., Waibl-Polania, Jessica, Wachsmuth, Lucas P., Miggelbrink, Alexandra M., Jackson, Joshua D., Cui, Xiuyu, Raj, Jude A., Tomaszewski, William H., Cook, Sarah L., Sampson, John H., Patel, Anoop P., Khasraw, Mustafa, Gunn, Michael D., and Fecci, Peter E.

Published
2023
Full Text
View/download PDF

2. Designing Clinical Trials for Combination Immunotherapy: A Framework for GlioblastomaCombining Immunotherapy for Glioblastoma

Author

Singh, Kirit, Batich, Kristen A, Wen, Patrick Y, Tan, Aaron C, Bagley, Stephen J, Lim, Michael, Platten, Michael, Colman, Howard, Ashley, David M, Chang, Susan M, Rahman, Rifaquat, Galanis, Evanthia, Mansouri, Alireza, Puduvalli, Vinay K, Reardon, David A, Sahebjam, Solmaz, Sampson, John H, Simes, John, Berry, Donald A, Zadeh, Gelareh, Cloughesy, Tim F, Mehta, Minesh P, Piantadosi, Steven, Weller, Michael, Heimberger, Amy B, and Khasraw, Mustafa

Subjects
Cancer, Immunization, Clinical Research, Rare Diseases, Brain Disorders, Vaccine Related, Clinical Trials and Supportive Activities, Brain Cancer, 5.1 Pharmaceuticals, Health and social care services research, 8.4 Research design and methodologies (health services), Development of treatments and therapeutic interventions, Brain Neoplasms, Glioblastoma, Humans, Immune Tolerance, Immunosuppression Therapy, Immunotherapy, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

Immunotherapy has revolutionized treatment for many hard-to-treat cancers but has yet to produce significant improvement in outcomes for patients with glioblastoma. This reflects the multiple and unique mechanisms of immune evasion and escape in this highly heterogeneous tumor. Glioblastoma engenders profound local and systemic immunosuppression and is remarkably effective at inducing T-cell dysfunction, posing a challenge to any immunotherapy-based approach. To overcome these mechanisms, multiple disparate modes of immune-oriented therapy will be required. However, designing trials that can evaluate these combinatorial approaches requires careful consideration. In this review, we explore the immunotherapy resistance mechanisms that have been encountered to date and how combinatorial approaches may address these. We also describe the unique aspects of trial design in both preclinical and clinical settings and consider endpoints and markers of response best suited for an intervention involving multiple agents.

Published
2022

3. Glioblastoma Clinical Trials: Current Landscape and Opportunities for ImprovementCurrent Glioblastoma Clinical Trial Landscape

Author

Bagley, Stephen J, Kothari, Shawn, Rahman, Rifaquat, Lee, Eudocia Q, Dunn, Gavin P, Galanis, Evanthia, Chang, Susan M, Nabors, Louis Burt, Ahluwalia, Manmeet S, Stupp, Roger, Mehta, Minesh P, Reardon, David A, Grossman, Stuart A, Sulman, Erik P, Sampson, John H, Khagi, Simon, Weller, Michael, Cloughesy, Timothy F, Wen, Patrick Y, and Khasraw, Mustafa

Subjects
Brain Disorders, Neurosciences, Rare Diseases, Brain Cancer, Clinical Research, Clinical Trials and Supportive Activities, Cancer, Adult, Brain Neoplasms, Glioblastoma, Humans, Research Design, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

Therapeutic advances for glioblastoma have been minimal over the past 2 decades. In light of the multitude of recent phase III trials that have failed to meet their primary endpoints following promising preclinical and early-phase programs, a Society for Neuro-Oncology Think Tank was held in November 2020 to prioritize areas for improvement in the conduct of glioblastoma clinical trials. Here, we review the literature, identify challenges related to clinical trial eligibility criteria and trial design in glioblastoma, and provide recommendations from the Think Tank. In addition, we provide a data-driven context with which to frame this discussion by analyzing key study design features of adult glioblastoma clinical trials listed on ClinicalTrials.gov as "recruiting" or "not yet recruiting" as of February 2021.

Published
2022

5. Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM: Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm.

Author

Sampson, John H., primary, Bexon, Martin, additional, Brem, Steven, additional, Brenner, Andrew J., additional, Coello, Melissa, additional, Das, Sunit, additional, Davi, Ruthie, additional, Desjardins, Annick, additional, Han, Seunggu Jude, additional, Kesari, Santosh, additional, Madduri Karanam, Sudhir, additional, Merchant, Rosemina, additional, Phillips, Joanna J., additional, To, Minh D, additional, Vogelbaum, Michael A., additional, Vrionis, Frank, additional, Merchant, Fahar, additional, and Butowski, Nicholas A., additional

Published
2024
Full Text
View/download PDF

6. IL-7 mediated upregulation of VLA-4 increases accumulation of adoptively transferred T lymphocytes in murine glioma.

Author

Singh, Kirit, primary, Hotchkiss, Kelly M, additional, Cook, Sarah L, additional, Noldner, Pamy, additional, Zhou, Ying, additional, Moelker, Eliese M, additional, Railton, Chelsea O, additional, Blandford, Emily E, additional, Puviindran, Bhairavy J, additional, Wallace, Shannon E, additional, Norberg, Pamela K, additional, Archer, Gary E, additional, Shaz, Beth, additional, Sampson, John H, additional, Khasraw, Mustafa, additional, and Fecci, Peter E, additional

Published
2024
Full Text
View/download PDF

10. Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

Author

Gromeier, Matthias, Brown, Michael C., Zhang, Gao, Lin, Xiang, Chen, Yeqing, Wei, Zhi, Beaubier, Nike, Yan, Hai, He, Yiping, Desjardins, Annick, Herndon, II, James E., Varn, Frederick S., Verhaak, Roel G., Zhao, Junfei, Bolognesi, Dani P., Friedman, Allan H., Friedman, Henry S., McSherry, Frances, Muscat, Andrea M., Lipp, Eric S., Nair, Smita K., Khasraw, Mustafa, Peters, Katherine B., Randazzo, Dina, Sampson, John H., McLendon, Roger E., Bigner, Darell D., and Ashley, David M.

Published
2021
Full Text
View/download PDF

15. Figure A1 from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

Author

Reardon, David A., primary, Desjardins, Annick, primary, Vredenburgh, James J., primary, O'Rourke, Donald M., primary, Tran, David D., primary, Fink, Karen L., primary, Nabors, Louis B., primary, Li, Gordon, primary, Bota, Daniela A., primary, Lukas, Rimas V., primary, Ashby, Lynn S., primary, Duic, J. Paul, primary, Mrugala, Maciej M., primary, Cruickshank, Scott, primary, Vitale, Laura, primary, He, Yi, primary, Green, Jennifer A., primary, Yellin, Michael J., primary, Turner, Christopher D., primary, Keler, Tibor, primary, Davis, Thomas A., primary, and Sampson, John H., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Data from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

Author

Reardon, David A., primary, Desjardins, Annick, primary, Vredenburgh, James J., primary, O'Rourke, Donald M., primary, Tran, David D., primary, Fink, Karen L., primary, Nabors, Louis B., primary, Li, Gordon, primary, Bota, Daniela A., primary, Lukas, Rimas V., primary, Ashby, Lynn S., primary, Duic, J. Paul, primary, Mrugala, Maciej M., primary, Cruickshank, Scott, primary, Vitale, Laura, primary, He, Yi, primary, Green, Jennifer A., primary, Yellin, Michael J., primary, Turner, Christopher D., primary, Keler, Tibor, primary, Davis, Thomas A., primary, and Sampson, John H., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure 7 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Author

Pham, Christina D., primary, Flores, Catherine, primary, Yang, Changlin, primary, Pinheiro, Elaine M., primary, Yearley, Jennifer H., primary, Sayour, Elias J., primary, Pei, Yanxin, primary, Moore, Colin, primary, McLendon, Roger E., primary, Huang, Jianping, primary, Sampson, John H., primary, Wechsler-Reya, Robert, primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 1 from Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells

Author

Nair, Smita K., primary, De Leon, Gabriel, primary, Boczkowski, David, primary, Schmittling, Robert, primary, Xie, Weihua, primary, Staats, Janet, primary, Liu, Rebecca, primary, Johnson, Laura A., primary, Weinhold, Kent, primary, Archer, Gary E., primary, Sampson, John H., primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Data from Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

Author

Batich, Kristen A., primary, Reap, Elizabeth A., primary, Archer, Gary E., primary, Sanchez-Perez, Luis, primary, Nair, Smita K., primary, Schmittling, Robert J., primary, Norberg, Pam, primary, Xie, Weihua, primary, Herndon, James E., primary, Healy, Patrick, primary, McLendon, Roger E., primary, Friedman, Allan H., primary, Friedman, Henry S., primary, Bigner, Darell, primary, Vlahovic, Gordana, primary, Mitchell, Duane A., primary, and Sampson, John H., primary

Published
2023
Full Text
View/download PDF

20. Data from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

Author

Reap, Elizabeth A., primary, Suryadevara, Carter M., primary, Batich, Kristen A., primary, Sanchez-Perez, Luis, primary, Archer, Gary E., primary, Schmittling, Robert J., primary, Norberg, Pamela K., primary, Herndon, James E., primary, Healy, Patrick, primary, Congdon, Kendra L., primary, Gedeon, Patrick C., primary, Campbell, Olivia C., primary, Swartz, Adam M., primary, Riccione, Katherine A., primary, Yi, John S., primary, Hossain-Ibrahim, Mohammed K., primary, Saraswathula, Anirudh, primary, Nair, Smita K., primary, Dunn-Pirio, Anastasie M., primary, Broome, Taylor M., primary, Weinhold, Kent J., primary, Desjardins, Annick, primary, Vlahovic, Gordana, primary, McLendon, Roger E., primary, Friedman, Allan H., primary, Friedman, Henry S., primary, Bigner, Darell D., primary, Fecci, Peter E., primary, Mitchell, Duane A., primary, and Sampson, John H., primary

Published
2023
Full Text
View/download PDF

21. Table S2 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

Author

Gedeon, Patrick C., primary, Schaller, Teilo H., primary, Chitneni, Satish K., primary, Choi, Bryan D., primary, Kuan, Chien-Tsun, primary, Suryadevara, Carter M., primary, Snyder, David J., primary, Schmittling, Robert J., primary, Szafranski, Scott E., primary, Cui, Xiuyu, primary, Healy, Patrick N., primary, Herndon, James E., primary, McLendon, Roger E., primary, Keir, Stephen T., primary, Archer, Gary E., primary, Reap, Elizabeth A., primary, Sanchez-Perez, Luis, primary, Bigner, Darell D., primary, and Sampson, John H., primary

Published
2023
Full Text
View/download PDF

24. Table S2 from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

Author

Reap, Elizabeth A., primary, Suryadevara, Carter M., primary, Batich, Kristen A., primary, Sanchez-Perez, Luis, primary, Archer, Gary E., primary, Schmittling, Robert J., primary, Norberg, Pamela K., primary, Herndon, James E., primary, Healy, Patrick, primary, Congdon, Kendra L., primary, Gedeon, Patrick C., primary, Campbell, Olivia C., primary, Swartz, Adam M., primary, Riccione, Katherine A., primary, Yi, John S., primary, Hossain-Ibrahim, Mohammed K., primary, Saraswathula, Anirudh, primary, Nair, Smita K., primary, Dunn-Pirio, Anastasie M., primary, Broome, Taylor M., primary, Weinhold, Kent J., primary, Desjardins, Annick, primary, Vlahovic, Gordana, primary, McLendon, Roger E., primary, Friedman, Allan H., primary, Friedman, Henry S., primary, Bigner, Darell D., primary, Fecci, Peter E., primary, Mitchell, Duane A., primary, and Sampson, John H., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 5 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Author

Pham, Christina D., primary, Flores, Catherine, primary, Yang, Changlin, primary, Pinheiro, Elaine M., primary, Yearley, Jennifer H., primary, Sayour, Elias J., primary, Pei, Yanxin, primary, Moore, Colin, primary, McLendon, Roger E., primary, Huang, Jianping, primary, Sampson, John H., primary, Wechsler-Reya, Robert, primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 4 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Author

Pham, Christina D., primary, Flores, Catherine, primary, Yang, Changlin, primary, Pinheiro, Elaine M., primary, Yearley, Jennifer H., primary, Sayour, Elias J., primary, Pei, Yanxin, primary, Moore, Colin, primary, McLendon, Roger E., primary, Huang, Jianping, primary, Sampson, John H., primary, Wechsler-Reya, Robert, primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Table 1 and 2 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Author

Pham, Christina D., primary, Flores, Catherine, primary, Yang, Changlin, primary, Pinheiro, Elaine M., primary, Yearley, Jennifer H., primary, Sayour, Elias J., primary, Pei, Yanxin, primary, Moore, Colin, primary, McLendon, Roger E., primary, Huang, Jianping, primary, Sampson, John H., primary, Wechsler-Reya, Robert, primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

28. Figure Legend and Supplementary Figure 1 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Author

Pham, Christina D., primary, Flores, Catherine, primary, Yang, Changlin, primary, Pinheiro, Elaine M., primary, Yearley, Jennifer H., primary, Sayour, Elias J., primary, Pei, Yanxin, primary, Moore, Colin, primary, McLendon, Roger E., primary, Huang, Jianping, primary, Sampson, John H., primary, Wechsler-Reya, Robert, primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 3 from Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells

Author

Nair, Smita K., primary, De Leon, Gabriel, primary, Boczkowski, David, primary, Schmittling, Robert, primary, Xie, Weihua, primary, Staats, Janet, primary, Liu, Rebecca, primary, Johnson, Laura A., primary, Weinhold, Kent, primary, Archer, Gary E., primary, Sampson, John H., primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure 6 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Author

Pham, Christina D., primary, Flores, Catherine, primary, Yang, Changlin, primary, Pinheiro, Elaine M., primary, Yearley, Jennifer H., primary, Sayour, Elias J., primary, Pei, Yanxin, primary, Moore, Colin, primary, McLendon, Roger E., primary, Huang, Jianping, primary, Sampson, John H., primary, Wechsler-Reya, Robert, primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

31. Figure S1 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

Author

Gedeon, Patrick C., primary, Schaller, Teilo H., primary, Chitneni, Satish K., primary, Choi, Bryan D., primary, Kuan, Chien-Tsun, primary, Suryadevara, Carter M., primary, Snyder, David J., primary, Schmittling, Robert J., primary, Szafranski, Scott E., primary, Cui, Xiuyu, primary, Healy, Patrick N., primary, Herndon, James E., primary, McLendon, Roger E., primary, Keir, Stephen T., primary, Archer, Gary E., primary, Reap, Elizabeth A., primary, Sanchez-Perez, Luis, primary, Bigner, Darell D., primary, and Sampson, John H., primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 2 from Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells

Author

Nair, Smita K., primary, De Leon, Gabriel, primary, Boczkowski, David, primary, Schmittling, Robert, primary, Xie, Weihua, primary, Staats, Janet, primary, Liu, Rebecca, primary, Johnson, Laura A., primary, Weinhold, Kent, primary, Archer, Gary E., primary, Sampson, John H., primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

33. Figure S2 from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

Author

Reap, Elizabeth A., primary, Suryadevara, Carter M., primary, Batich, Kristen A., primary, Sanchez-Perez, Luis, primary, Archer, Gary E., primary, Schmittling, Robert J., primary, Norberg, Pamela K., primary, Herndon, James E., primary, Healy, Patrick, primary, Congdon, Kendra L., primary, Gedeon, Patrick C., primary, Campbell, Olivia C., primary, Swartz, Adam M., primary, Riccione, Katherine A., primary, Yi, John S., primary, Hossain-Ibrahim, Mohammed K., primary, Saraswathula, Anirudh, primary, Nair, Smita K., primary, Dunn-Pirio, Anastasie M., primary, Broome, Taylor M., primary, Weinhold, Kent J., primary, Desjardins, Annick, primary, Vlahovic, Gordana, primary, McLendon, Roger E., primary, Friedman, Allan H., primary, Friedman, Henry S., primary, Bigner, Darell D., primary, Fecci, Peter E., primary, Mitchell, Duane A., primary, and Sampson, John H., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 1 from Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells

Author

Nair, Smita K., primary, De Leon, Gabriel, primary, Boczkowski, David, primary, Schmittling, Robert, primary, Xie, Weihua, primary, Staats, Janet, primary, Liu, Rebecca, primary, Johnson, Laura A., primary, Weinhold, Kent, primary, Archer, Gary E., primary, Sampson, John H., primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figure 2 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Author

Pham, Christina D., primary, Flores, Catherine, primary, Yang, Changlin, primary, Pinheiro, Elaine M., primary, Yearley, Jennifer H., primary, Sayour, Elias J., primary, Pei, Yanxin, primary, Moore, Colin, primary, McLendon, Roger E., primary, Huang, Jianping, primary, Sampson, John H., primary, Wechsler-Reya, Robert, primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Table 2 from Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells

Author

Nair, Smita K., primary, De Leon, Gabriel, primary, Boczkowski, David, primary, Schmittling, Robert, primary, Xie, Weihua, primary, Staats, Janet, primary, Liu, Rebecca, primary, Johnson, Laura A., primary, Weinhold, Kent, primary, Archer, Gary E., primary, Sampson, John H., primary, and Mitchell, Duane A., primary

Published
2023
Full Text
View/download PDF

37. Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery

Author

Carpenter, David J., primary, Fairchild, Andrew T., additional, Adamson, Justus D., additional, Fecci, Peter E., additional, Sampson, John H., additional, Herndon, James E., additional, Torok, Jordan A., additional, Mullikin, Trey C., additional, Kim, Grace J., additional, Reitman, Zachary J., additional, Kirkpatrick, John P., additional, and Floyd, Scott R., additional

Published
2023
Full Text
View/download PDF

39. Targeting the IL4 Receptor with MDNA55 in Patients with Recurrent Glioblastoma: Results of a Phase 2b Trial

Author

Sampson, John H, primary, Singh Achrol, Achal, additional, Aghi, Manish K, additional, Bankiewiecz, Krystof, additional, Bexon, Martin, additional, Brem, Steven, additional, Brenner, Andrew, additional, Chandhasin, Chandtip, additional, Chowdhary, Sajeel, additional, Coello, Melissa, additional, Ellingson, Benjamin M, additional, Floyd, John R, additional, Han, Seunggu, additional, Kesari, Santosh, additional, Mardor, Yael, additional, Merchant, Fahar, additional, Merchant, Nina, additional, Randazzo, Dina, additional, Vogelbaum, Michael, additional, Vrionis, Frank, additional, Wembacher-Schroeder, Eva, additional, Zabek, Miroslaw, additional, and Butowski, Nicholas, additional

Published
2023
Full Text
View/download PDF

40. Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.

Author

Sampson, John H, Achrol, Achal Singh, Aghi, Manish K, Bankiewicz, Krystof, Bexon, Martin, Brem, Steven, Brenner, Andrew, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Ellingson, Benjamin M, Floyd, John R, Han, Seunggu, Kesari, Santosh, Mardor, Yael, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, and Vrionis, Frank

Published
2023
Full Text
View/download PDF

43. Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.

Author

Sampson, John H., primary, Batich, Kristen A, additional, Mitchell, Duane Anthony, additional, Herndon, James Emmett, additional, Broadwater, Gloria, additional, Healy, Patrick, additional, Sanchez-Perez, Luis, additional, Nair, Smita, additional, Congdon, Kendra, additional, Norberg, Pamela, additional, Weinhold, Kent J., additional, Archer, Gerald E., additional, Reap, Elizabeth A., additional, Xie, Weihua, additional, McLendon, Roger E., additional, Reardon, David A., additional, Vredenburgh, James J., additional, Friedman, Henry S., additional, Bigner, Darell, additional, and Friedman, Allan H., additional

Published
2022
Full Text
View/download PDF

44. A phase 1 trial of D2C7-it in combination with an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma (MG).

Author

Desjardins, Annick, primary, Chandramohan, Vidyalakshmi, additional, Landi, Daniel B, additional, Johnson, Margaret O., additional, Khasraw, Mustafa, additional, Peters, Katherine B., additional, Low, Justin, additional, Herndon, James Emmett, additional, Threatt, Stevie, additional, Bullock, Chevelle A., additional, Lipp, Eric S., additional, Sampson, John H., additional, Friedman, Allan H., additional, Friedman, Henry S., additional, Ashley, David M., additional, Knorr, David, additional, and Bigner, Darell D., additional

Published
2022
Full Text
View/download PDF

45. A phase 0/surgical window-of-opportunity study in progress, evaluating evolocumab in patients with high-grade glioma or glioblastoma.

Author

Singh, Kirit, primary, Foster, Matthew, additional, Miller, Elizabeth S., additional, Gregory, Simon, additional, Weinhold, Kent J., additional, Ashley, David M., additional, Desjardins, Annick, additional, Low, Justin, additional, Peters, Katherine B., additional, Severance, Erin, additional, Jaggers, Denise, additional, Friedman, Henry S., additional, Johnson, Margaret O., additional, Friedman, Allan H., additional, Keir, Stephen T., additional, Herndon, James Emmett, additional, Li, Chuan-Yuan, additional, Fecci, Peter E., additional, Sampson, John H., additional, and Khasraw, Mustafa, additional

Published
2022
Full Text
View/download PDF

46. Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143

Author

Omuro, Antonio, primary, Reardon, David A, additional, Sampson, John H, additional, Baehring, Joachim, additional, Sahebjam, Solmaz, additional, Cloughesy, Timothy F, additional, Chalamandaris, Alexandros-Georgios, additional, Potter, Von, additional, Butowski, Nicholas, additional, and Lim, Michael, additional

Published
2022
Full Text
View/download PDF

47. Validation of an Online Calculator to Predict Short-term Postoperative Outcomes in Patients with Metastatic Brain Tumors

Author

Kang, Jennifer H., primary, Murphy, Kelly Ryan, additional, McCray, Edwin, additional, Ramirez, Luis, additional, Price, Meghan, additional, Dalton, Tara E., additional, Peters, Katherine B., additional, Desjardins, Annick, additional, Johnson, Margaret O., additional, Friedman, Allan H., additional, Cook, Steven, additional, Codd, Patrick J., additional, Sampson, John H., additional, Zomorodi, Ali R., additional, Fecci, Peter E., additional, and Goodwin, C. Rory, additional

Published
2021
Full Text
View/download PDF

49. Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study

Author

Kim, Grace J., primary, Buckley, Evan D., additional, Herndon, James E., additional, Allen, Karen J., additional, Dale, Tyketra S., additional, Adamson, Justus D., additional, Lay, Lam, additional, Giles, William M., additional, Rodrigues, Anna E., additional, Wang, Zhiheng, additional, Kelsey, Chris R., additional, Torok, Jordan A., additional, Chino, Junzo P., additional, Fecci, Peter E., additional, Sampson, John H., additional, Anders, Carey K., additional, Floyd, Scott R., additional, Yin, Fang-Fang, additional, and Kirkpatrick, John P., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results